Rankings
▼
Calendar
VERA FY 2025 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VERA
Vera Therapeutics, Inc.
$3B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$468,000
Operating Income
-$315M
Net Income
-$300M
EPS (Diluted)
$-4.66
Cash Flow
Operating Cash Flow
-$241M
Free Cash Flow
-$242M
Stock-Based Comp.
$38M
Balance Sheet
Total Assets
$735M
Total Liabilities
$130M
Stockholders' Equity
$605M
Cash & Equivalents
$355M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$468,000
$0
—
Operating Income
-$315M
-$167M
-88.7%
Net Income
-$300M
-$152M
-96.9%
← Q4 2024
All Quarters
Q1 2025 →